dexefaroxan has been researched along with s 9871 in 1 studies
| Studies (dexefaroxan) | Trials (dexefaroxan) | Recent Studies (post-2010) (dexefaroxan) | Studies (s 9871) | Trials (s 9871) | Recent Studies (post-2010) (s 9871) |
|---|---|---|---|---|---|
| 15 | 0 | 4 | 12 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pauwels, PJ; Rauly, I; Wurch, T | 1 |
1 other study(ies) available for dexefaroxan and s 9871
| Article | Year |
|---|---|
Dissimilar pharmacological responses by a new series of imidazoline derivatives at precoupled and ligand-activated alpha 2A-adrenoceptor states: evidence for effector pathway-dependent differential antagonism.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Benzofurans; Benzopyrans; Binding Sites; Brimonidine Tartrate; CHO Cells; Cricetinae; Cyclic AMP; Epinephrine; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Idazoxan; Imidazoles; Pertussis Toxin; Quinoxalines; Rats; Receptors, Adrenergic, alpha-2; Sulfur Radioisotopes; Tumor Cells, Cultured | 2003 |